Clinical trial
Impact of Exocrine Pancreatic Insufficiency Associated With Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy on Gut Microbiota, Immunological Changes and Quality of Life
NCT05480241 is registered in ClinicalTrials.gov with Unidade Local de Saúde de Coimbra, EPE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Exocrine Pancreatic Insufficiency Associated With Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy on Gut Microbiota, Immunological Changes and Quality of Life
- Lead sponsor
- Unidade Local de Saúde de Coimbra, EPE
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 84 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis, exocrine pancreatic insufficiency, gut microbiota, immunology